Faramarz Ismail-Beigi MD, PhDProfessor of Medicine, Physiology and Biophysics, and Biochemistry, Case Western Reserve University, Cleveland, Ohio
Dr. Ismail-Beigi was born in Tehran, Iran in 1941. He obtained his MD degree from Johns Hopkins University in 1968 and continued to do his residency in Internal Medicine there. He obtained a PhD in Biophysics in 1972 from University of California (San Francisco and Berkeley). From 1972 to 1982, he was professor and Chairman of Medicine at Shiraz University in Iran. He spent 10 years (1984-1993) as Professor of Medicine at Columbia University in New York before becoming Chief of Endocrinology at Case Western Reserve University in Cleveland, Ohio (1993-2009). He currently serves as a Professor of Medicine, Physiology, and Biochemistry at Case.
His interests are in teaching and in clinical and basic research in type 2 diabetes, glucose transporter biology, and insulin action. He was the Principal Investigator of the BARI2D trial, the ACCORD trial for the Ohio/Michigan Network, and is the PI of the ongoing NIH-funded GRADE trial in Cleveland (all focused on Type 2 Diabetes). Finally, over the past 15 years, he is conducting research projects on novel insulin formulations with improved action profiles; these projects are funded by the NIH, Helmsley Foundation, and Juvenile Diabetes Research Foundation.